admin
The Centers for Disease Control and Prevention just dropped a finding that should give parents and policymakers pause: emergency‑department visits tied to cannabis hyperemesis syndrome (CHS) climbed sharply after hospitals started using a new diagnosis code. Before anyone lights a celebratory joint, remember that this is not just a coding story — it’s a warning about a generation coping badly and an industry cashing in.
New CDC MMWR shows CHS visits rose after ICD‑10 code R11.16
The CDC’s MMWR report used the new ICD‑10‑CM code R11.16 for cannabinoid hyperemesis syndrome to look at trends from January 2023 through May 2026. Once that code went live in October 2025, CHS visits jumped from about 3.35 per 10,000 emergency visits to 11.26 per 10,000 the next month. On average after October 2025, CHS visit rates were roughly 3.7 times higher than the earlier period. The numbers are real, and the report flags that people aged 15–24 and females were hit especially hard.
Don’t be fooled — better tracking explains part of the rise
Before October 2025, CHS had no single billable code, so cases were easy to miss. The new code improved tracking and clinician recognition, which likely explains a big slice of the abrupt increase. That caveat matters. Still, separate federal survey data show roughly 21.4 million Americans now use cannabis daily or nearly daily, so more exposure means more risk. Add in surveys showing high rates of anxiety, depression, and self‑medication in Gen Z, and you get a picture of young people using cannabis as a bandage for deeper mental‑health wounds.
Policy failures meet booming cannabis profits
Here’s the part politicians and industry lobbyists don’t like: legalization and commercialization have made potent THC products easy to get, and Big Weed is raking in billions while public health strains. The CDC recommends better clinician education, routine cannabis screening in emergency settings, and prevention efforts for youth. Fine. But those steps won’t fix the root problem: a legal market that normalizes frequent use, especially among vulnerable young people. If state treasuries cheer $47 billion in sales while ERs see more vomiting, psychosis, and cognitive harm, that’s a lousy trade‑off dressed up as progress.
Final word: Act before trend becomes crisis
We should accept the CDC’s findings for what they are: a new, clearer view of a real harm. Coding changes explain part of the spike, but rising daily use and youth self‑medication suggest this won’t vanish on its own. Conservatives who believe in responsibility and strong communities should demand sensible limits: tighter youth protections, honest public education about risks, and funding for mental‑health care so kids don’t reach for a vape pen when they need real help. If policymakers continue to treat cannabis like harmless pocket change, expect more trips to the ER — and fewer excuses when the bill comes due.
